VCYT

SEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 4

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,934

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.00 to $24.98. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 3

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

SEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 2

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,208

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

SEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 1

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,462

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

SEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · derivative · entry 8

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,194

Underlying: Common Stock · 19,056 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · derivative · entry 7

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,017 shares

Expires 2023-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

F4 · derivative.exercise_date: The option is fully vested.

SEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · derivative · entry 6

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,927 shares

Expires 2022-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

F4 · derivative.exercise_date: The option is fully vested.

SEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 5

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,714

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.55 to $25.60. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 4

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,550

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.55 to $25.54. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 3

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

SEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 2

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

SEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 1

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

SEC source: 0001384101-19-000034 · wf-form4_155501741939389.xml · derivative · entry 4

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,500

Underlying: Common Stock · 8,000 shares

Expires 2022-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0001384101-19-000034 · wf-form4_155501741939389.xml · nonDerivative · entry 2

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,292

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.98 to $25.68. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-19-000034 · wf-form4_155501741939389.xml · nonDerivative · entry 1

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.

SEC source: 0001384101-19-000032 · wf-form4_155251071460809.xml · nonDerivative · entry 3

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,292

SEC source: 0001384101-19-000032 · wf-form4_155251071460809.xml · derivative · entry 5

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,500

Underlying: Common Stock · 8,000 shares

Expires 2022-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0001384101-19-000032 · wf-form4_155251071460809.xml · nonDerivative · entry 2

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,592

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $19.79 to $20.23. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-19-000032 · wf-form4_155251071460809.xml · nonDerivative · entry 1

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.

SEC source: 0000904454-19-000305 · edgar.xml · nonDerivative · entry 8

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By DP VIII Associates, L.P.

Disclosed balance after: 0

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.

SEC source: 0000904454-19-000305 · edgar.xml · nonDerivative · entry 7

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Domain Partners VIII, L.P.

Disclosed balance after: 1,231,647

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.

SEC source: 0001384101-19-000030 · wf-form4_155182249111385.xml · derivative · entry 3

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,875

Underlying: Common Stock · 17,625 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001384101-19-000030 · wf-form4_155182249111385.xml · nonDerivative · entry 2

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,624

F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $20.00 to $20.77. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-19-000030 · wf-form4_155182249111385.xml · nonDerivative · entry 1

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,249

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001384101-19-000018 · wf-form4_155174356261401.xml · nonDerivative · entry 2

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,714

F2 · shares: The reporting person is reporting the withholding of 2,282 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 6,667 Restricted Stock Units granted on March 3, 2017. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4.

SEC source: 0001384101-19-000018 · wf-form4_155174356261401.xml · nonDerivative · entry 1

Hall Christopher M · CIK 0001449535 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,996

F1 · shares: The reporting person is reporting the withholding of 1,459 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,675 Restricted Stock Units granted on March 2, 2018. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4.

SEC source: 0001384101-19-000028 · wf-form4_155174484228465.xml · nonDerivative · entry 3

Kennedy Keith · CIK 0001543503 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,550

F4 · shares: The reporting person is reporting the withholding of 1,053 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,575 Restricted Stock Units granted on March 2, 2018. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4.

F5 · balance_after: Includes 2,244 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2018 and 2,245 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2019.

SEC source: 0001384101-19-000020 · wf-form4_155174382498976.xml · nonDerivative · entry 1

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,592

F1 · shares: The reporting person is reporting the withholding of 3,949 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 7,500 Restricted Stock Units granted on March 2, 2018. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4.

SEC source: 0000904454-19-000305 · edgar.xml · nonDerivative · entry 6

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By DP VIII Associates, L.P.

Disclosed balance after: 12,193

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.

SEC source: 0000904454-19-000305 · edgar.xml · nonDerivative · entry 5

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Domain Partners VIII, L.P.

Disclosed balance after: 1,646,605

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.

SEC source: 0001384101-19-000016 · wf-form4_155139072059287.xml · derivative · entry 7

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2029-02-27

F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001384101-19-000016 · wf-form4_155139072059287.xml · nonDerivative · entry 4

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,541

F4 · kind: Restricted stock units awarded on February 28, 2019 vest 25% on March 2, 2020 and 1/16 per quarter thereafter, based on continuing service on each vesting date.

SEC source: 0000904454-19-000305 · edgar.xml · nonDerivative · entry 4

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By DP VIII Associates, L.P.

Disclosed balance after: 14,216

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.

SEC source: 0000904454-19-000305 · edgar.xml · nonDerivative · entry 3

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Domain Partners VIII, L.P.

Disclosed balance after: 1,919,582

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.

SEC source: 0000904454-19-000305 · edgar.xml · nonDerivative · entry 2

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By DP VIII Associates, L.P.

Disclosed balance after: 14,423

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.

SEC source: 0000904454-19-000305 · edgar.xml · nonDerivative · entry 1

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Domain Partners VIII, L.P.

Disclosed balance after: 1,947,375

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.

SEC source: 0001384101-19-000026 · wf-form4_155174465446131.xml · nonDerivative · entry 1

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by jVen Capital, LLC

Disclosed balance after: 204,653

F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $20.03 to $20.90. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F2 · ownership.nature: The Reporting Person is the sole managing member of jVen Capital, LLC.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · derivative · entry 16

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,271

Underlying: Common Stock · 12,396 shares

Expires 2027-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · derivative · entry 15

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,773

Underlying: Common Stock · 4,166 shares

Expires 2026-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 15, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · derivative · entry 14

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,253

Underlying: Common Stock · 8,749 shares

Expires 2026-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · derivative · entry 13

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,667

Underlying: Common Stock · 11,667 shares

Expires 2025-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2016, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · derivative · entry 12

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

Underlying: Common Stock · 397 shares

Expires 2024-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option is fully vested and fully exercisable.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · derivative · entry 11

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2029-02-27

F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · nonDerivative · entry 10

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,587

F5 · shares: The reporting person is reporting the withholding of 813 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,350 Restricted Stock Units granted on March 2, 2018. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · nonDerivative · entry 9

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,400

F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $21.14 to $21.39. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · nonDerivative · entry 8

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,700

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $20.11 to $21.10. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · nonDerivative · entry 7

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,775

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · nonDerivative · entry 6

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,379

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · nonDerivative · entry 5

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001384101-19-000024 · wf-form4_155174432116817.xml · nonDerivative · entry 4

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.